3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Classical hematology
1
Conditions
Venous Thromboembolism
1
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Hemorrhage
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
ruxolitinib
12
fludarabine phosphate
5
Whole-Body Irradiation
5
Cyclophosphamide
5
Tacrolimus
4
Peripheral Blood Stem Cell Transplantation
4
Mycophenolic Acid
4
Hydroxyurea
4
bomedemstat
3
Stem Cell Transplantation
3
Specimen Handling
3
Busulfan
3
Biopsy
3
Aspirin
3
fludarabine
2
Phlebotomy
2
Methotrexate
2
Melphalan
2
Injections
2
Azacitidine
2
venetoclax
1
veliparib
1
umbralisib
1
piperine
1
pevonedistat
1
methanesulfonic acid
1
itacitinib
1
iadademstat
1
givinostat hydrochloride
1
givinostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Polycythemia Vera
×
N(4)-oleylcytosine arabinoside
×
1 year
×
Clear all
NCT05198960
2026-03-20
AVAJAK
University Hospital, Brest
Phase 3
Recruiting
1,308 enrolled